Objectives:To study changes in lipid profile in patients with rheumatoid arthritis (RA) and to evaluate the relation between lipid profile and disease severity of RA. Design: Cross-sectional study. Patients:Patients with rheumatoid arthritis (RA) according to 2010 ACR/EULAR classification criteria for RA (n = 150). Methods: Demographic data, arthritis history, medical and therapeutic history were evaluated. Disease activity was evaluated using DAS28 (ESR). Immunological investigations included RF, ESR, CRP, and anti-CCP.Lipid profile levels were measured. Results:Raised TG was found in 38 (25.3 %) of patients, raised TC was found in 69 (46 %) of patients and decreased HDL-C was detected in 85 (56.7 %) of the patients.
INTRODUCTION
Rheumatoid arthritis (RA) is one of the most prevalent chronic inflammatory diseases. It primarily involves the joints,with extra-articular manifestations (1) . RA is the most common inflammatory arthritis (2) . Patients with RA have high mortality rate when compared to the general population, with cardiovascular disease (CVD) contributing up to 50% of all deaths (3) .The main determinants of cardiovascular risk in the general population are the concentrations of serum low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol (4) .
In RA, high-grade inflammation and associated factors, such as increased levels of CRP and inflammatory cytokines, can influence commonly measured lipid levels, leading to their misinterpretation (5) .Studies in patients with early RA demonstrate normal or mildly elevated total cholesterol (TC), LDL and triglycerides (TG), associated with decreased HDL levels (6, 7) . By contrast,highly active RA is associated with decreased TC and LDL levels (6) .
The dynamic changes that occur in traditionally assessed lipid profiles during the course of RA are influenced by various factors. Quantitative and qualitative changes in lipid homeostasis mirror the action and counteraction of the inflammatory disease and the evoked metabolic alterations (8, 9) . The aim of this study was tostudy changes in lipid profile in patients with RA and to evaluate the relation between lipid profile and disease severity of RA.
PATIENTS AND METHODS:
This study included 150patients; diagnosed as having RA according to the 2010 ACR/EULAR classification criteria forRA (10) ; attending Rheumatology clinics at Sohag University Hospitals.The 
II-Joint examination and disease activity:
Examination of 28 joints of the hands, wrists, elbows, shoulders, and knees was done with count of the swollen and tender joints to calculate DAS28. The disease activity was evaluated using DAS28 (ESR) according to the equation [DAS28 (ESR) = 0.56 × √ (TJC 28) + 0.28 √ (SJC 28) + 0.70 × ln (ESR) + 0.014 × GH (range, 0-9)]. High disease activity was considered as DAS28 > 5.1, moderate as DAS28 > 3.2-≤5.1, and low disease activity in the range 2.6-3.2. DAS28 ≤ 2.6 indicated disease remission (11) .
III-Laboratory investigations: III.A) Immunological tests: 1-Rheumatoid factor (RF):It was measured in patients' sera by rapid latex agglutination test using AVITEX RF kit (Omega diagnostics LTD,
Scotland, United Kingdom).Positive results were considered at RF serum concentration above 8 IU/ml.
2-Erythrocyte Sedimentation Rate (ESR): ESR was measured in the anticoagulated blood of the patients by
Wintrobe's method. The reference range of first hour ESR was 3-5 mm/hr (for females) and 7-12 mm/hr (for males).
3-C-reactive protein(CRP):
It was measured in patients' sera by rapid latex agglutination test using AVITEX CRP kit (Omega Diagnostics LTD, Scotland, United Kingdom).Positive results were considered at CRP serum concentration above 6 mg/Litre.
4-Anti-cyclic citrullinated peptides (Anti-CCP):was
measured by a chemiluminescentmicroparticle immunoassay using ARCHITECT Anti-CCP Reagent Kit "1P65" (Axis-Shield Diagnostics LTD, Dundee, United Kingdom). Values more than 5 IU/ml were considered positive. III.B) Lipid profile:Serum TC, HDL-C and TG were assessed by enzymatic colorimetric methods using commercially available kits on Cobas C311 analyzer (Roche Diagnostics GmbH, Germany).TC between 50 and 200 mg/dl, TG between 40 and 150 mg/dl, HDL-C more than 35 mg/dl and LDL-C less than 110 mg/dl were considered normal values.
IV-Statistical analysis:
Data were analyzed usingStatistical Package for Social Sciences soft ware program (SPSS, version 24).Qualitative variables were recorded as frequencies and percentages and were compared by chi-square test.Quantitative variables were presented as means ± standard deviation (SD)for normally distributed data and median with interquartile range (IQR) for non-normally distributed dataand were compared by independent ttest.Pearson's correlation test was used to study the correlation between DAS-28 and different parameters of lipid pofile.P value < 0.05 was considered statistically significant. 
RESULTS
The mean age ± SD of the patients was 45.01±11.05 years, with 126 (84%) of themwere females, and 102 (68%) were from rural areas.Only 17 (11.3%) of the patients were smokers.The mean ± SD age at the disease onset of the study population was 35.66 ± 10.60 years.The mean ± SD duration of the disease was 9.60±7.35 years. The course of the disease was progressive in all patients. Morning stiffness was recorded in 77 (51.3%) of the study population. History of hypertension was found in 28 (18.7%) of the study population and DM was documented in 19 (12.7%). History of CVDs was found in 4 (2.7%) of the study population; with history of ischemia in 3 patients and history of myocardial infarction in one patient. History of stroke was found in 1 patient (0.7%). History of use of NSAIDs was found in 146 (97.3%) of the study population. Use of steroids (prednisone/ prednisolone) was demonstrated in 61 (40.7%). Regarding DMARDs; most patients (61.3%) were using two drugs. Hydroxychloroquinewas used by 112(74.7%), methotrexate by 106 (70.7%),leflunomideby 46(30.7%), and sulfasalazine by 31(20.7%)of the study population.
The mean values of DAS28 and its different components are shown in table 1. Categories of disease activity in the study population according to DAS28 are demonstrated in table 2. The CRP was positive in 136 (90.7%) of the study population, with median value of 12 mg/L (IQR: 8-25 mg/L). The RF was positive in 97 (64.7%) of the study population, with median value of 36 IU/ml (IQR: 8-128 IU/ml). The anti-CCP was positive in 99 (66%) of the study population. In the current; there was positive correlation between cholesterol level and DAS28, and negative correlation between DAS28 and HDL-C levels. This was in accordance with previous studies demonstrating correlations between disease activity and dyslipidemias (16-18) . This finding may reflect the role of inflammation in dyslipidemias in rheumatoid patients. 
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